Vinay Prasad Exits FDA: Abrupt Resignation of CBER Director & Chief Medical Officer After 3 Months | Sarepta Gene Therapy Controversy, Political Pressure & Regulatory Impact
Vinay Prasad Exits FDA: Abrupt Resignation of CBER Director & Chief Medical Officer After 3 Months | Sarepta Gene Therapy Controversy, Political Pressure & Regulatory Impact Key Takeaways Abrupt Exit : Vinay Prasad resigned as FDA’s biologics chief after less than three months amid political pressure and drug approval controversies . Sarepta Controversy : His scrutiny of Elevidys , a Duchenne muscular dystrophy therapy, led to shipment halts after a patient death, reversed days before his departure . Political Targeting : Right-wing activist Laura Loomer spearheaded a smear campaign, branding Prasad a “progressive saboteur” for past critiques of Trump and COVID policies . Scientific Clash : Prasad overruled FDA scientists on COVID vaccines, limiting boosters to high-risk groups, drawing ire from public health experts . The Resignation Heard ‘Round the Beltway Vinay Prasad quit on a Tuesday. The FDA’s biologics chief walked out after 89 days, a blip in bureaucra...